Startup Dossier
Dianosic
Clinical-stage biotech pioneering drug delivery solutions for chronic respiratory diseases (allergic rhinitis, chronic rhinosinusitis) and central nervous system (CNS) disorders, based on its proprietary intranasal bioresorbable insert technology.
active
Typestartup
SectorBioTech
LocationStrasbourg, France
About
Clinical-stage biotech pioneering drug delivery solutions for chronic respiratory diseases (allergic rhinitis, chronic rhinosinusitis) and central nervous system (CNS) disorders, based on its proprietary intranasal bioresorbable insert technology.
Structural DNA
Legal Name
Dianosic
SIREN
830930889
Founders & Team
Funding Lineage
Series A
Aptar (Lead)
€7.0M
Sept 2025
Seed
Bpifrance (Lead)
€4.7M
Feb 2023
Programs
i-Lab
2019